Abcellera receives authorization from health canada to initiate a phase 1 clinical trial of abcl575

Vancouver, british columbia--(business wire)---- $abcl--abcellera receives authorization from health canada to initiate a phase 1 clinical trial of abcl575.
ABCL Ratings Summary
ABCL Quant Ranking